Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors

• Ngā kaituhi matua: Sara Ranjbar (Author), Najmeh Edraki (Author), Mahsima Khoshneviszadeh (Author), Alireza Foroumadi (Author), Ramin Miri (Author), Mehdi Khoshneviszadeh (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Mammalian target of rapamycin (mTOR) is a phosphoinositide 3-kinase-related protein kinase which controls cell growth and is frequently deregulated in many cancers. Therefore, mTOR inhibitors are used as antineoplastic agents for cancer treatment. In this study, 1,2,4-triazine derivatives containing...